A Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Hodgkin's Lymphoma
Clinical trial NCT04665063 · UNKNOWN
Trial details
- NCT number
- NCT04665063
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-22
- Primary completion
- 2023-10-21
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.